Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration

Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world and complement factor H (CFH) polymorphism has been found to associated with the AMD. We performed a meta-analysis to estimate the magnitude of the gene effect and the possible mode of action. A meta-analysis of eight studies assessing association between the CFH Y402H polymorphism and AMD was performed. Data extraction and study quality assessment were performed in duplicate, and heterogeneity and publication bias were explored. There was strong evidence for association between CFH and AMD, with those having CC and TC genotypes being roughly six and 2.5 times more likely to have AMD than patients with TT genotype, suggesting a co-dominant, multiplicative genetic model. The population attributable risk for the CC/TC genotype is 58.9%, i.e. the CFH polymorphism is involved in over half of all AMD. This meta-analysis summarizes the strong evidence for an association between CFH and AMD and indicates a multiplicative model with each C allele increasing the odds of AMD by 2.5-fold. This result is at least as important at the population level as ApoE4 and Alzheimer’s disease, playing a role in almost 60% of AMD at the population level.

[1]  S. Rodríguez de Córdoba,et al.  The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.

[2]  C. Pang,et al.  Differential occurrence of mutations causative of eye diseases in the Chinese population , 2002, Human mutation.

[3]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[4]  J. Ott,et al.  Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. , 2003, Archives of ophthalmology.

[5]  Douglas G. Altman,et al.  Systematic reviews in health care : meta-analysis in context , 2008 .

[6]  E. Souied,et al.  Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. , 2005, Molecular vision.

[7]  Johannes R. Vingerling,et al.  The prevalence of age-related maculopathy in the Rotterdam Study. , 1995, Ophthalmology.

[8]  G. Abecasis,et al.  Meta-analysis of genome scans of age-related macular degeneration. , 2005, Human molecular genetics.

[9]  R. Klein,et al.  Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. , 2003, Ophthalmology.

[10]  Ammarin Thakkinstian,et al.  A method for meta‐analysis of molecular association studies , 2005, Statistics in medicine.

[11]  R. Wormald,et al.  Is the incidence of registrable age-related macular degeneration increasing? , 1996, The British journal of ophthalmology.

[12]  M. Klein,et al.  Heredity and age-related macular degeneration. Observations in monozygotic twins. , 1994, Archives of ophthalmology.

[13]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Jian Ge,et al.  CFH Y402H Confers Similar Risk of Soft Drusen and Both Forms of Advanced AMD , 2005, PLoS medicine.

[15]  S M Meyers,et al.  A twin study of age-related macular degeneration. , 1995, American journal of ophthalmology.

[16]  S. Santangelo,et al.  A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. , 2003, American journal of human genetics.

[17]  Margaret A. Pericak-Vance,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .

[18]  T. Matise,et al.  Age-related macular degeneration--a genome scan in extended families. , 2003, American journal of human genetics.

[19]  G. Silvestri,et al.  Is genetic predisposition an important risk factor in age-related macular degeneration? , 1994, Eye.

[20]  R. Klein,et al.  A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. , 2003, American journal of human genetics.

[21]  A. Moore,et al.  Genetic susceptibility to age related macular degeneration , 2000, Journal of medical genetics.

[22]  Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. , 2004, American journal of human genetics.

[23]  Jurg Ott,et al.  Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. , 2005, American journal of human genetics.

[24]  S G Thompson,et al.  Investigating underlying risk as a source of heterogeneity in meta-analysis. , 1997, Statistics in medicine.

[25]  C. Klaver,et al.  The genetics of age-related macular degeneration. , 1999, Molecular vision.

[26]  J. Thompson,et al.  The choice of a genetic model in the meta-analysis of molecular association studies. , 2005, International journal of epidemiology.

[27]  M. Iannuzzi,et al.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. , 2003, American journal of human genetics.

[28]  J. Haines,et al.  Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. , 2004, American journal of human genetics.

[29]  Familial Aggregation of Age-related Maculopathy , 1997 .

[30]  S. Sharp,et al.  Explaining heterogeneity in meta-analysis: a comparison of methods. , 1999 .

[31]  G. Abecasis,et al.  Age-Related Macular Degeneration: A High-Resolution Genome Scan for Susceptibility Loci in a Population Enriched for Late-Stage Disease , 2004 .

[32]  L. V. Johnson,et al.  Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.

[33]  A Hofman,et al.  Genetic risk of age-related maculopathy. Population-based familial aggregation study. , 1998, Archives of ophthalmology.

[34]  Harold Snieder,et al.  Genetic influence on early age-related maculopathy: a twin study. , 2002, Ophthalmology.

[35]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  S. Sivaprasad,et al.  The complement system and age-related macular degeneration , 2006, Eye.

[37]  R. Klein,et al.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[38]  T. Matise,et al.  Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. , 1998, Archives of ophthalmology.

[39]  S. Fisher,et al.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .

[40]  J. Eisman,et al.  Meta‐Analysis of Molecular Association Studies: Vitamin D Receptor Gene Polymorphisms and BMD as a Case Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[42]  D. Clayton,et al.  Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. , 2006, Investigative ophthalmology & visual science.

[43]  Alston Callahan,et al.  The role of inflammation in the pathogenesis of age-related macular degeneration. , 2006, Survey of ophthalmology.

[44]  J. Haines,et al.  A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy , 2002, Ophthalmic genetics.

[45]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[46]  R. Klein,et al.  Sibling correlations and segregation analysis of age‐related maculopathy: The beaver dam eye study , 1994, Genetic epidemiology.

[47]  D. Weeks,et al.  Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. , 2001, American journal of ophthalmology.

[48]  P. Zandi,et al.  Apolipoprotein E Genotype and Mortality: Findings from the Cache County Study , 2005, Journal of the American Geriatrics Society.

[49]  S G Thompson,et al.  Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated , 1994, BMJ.

[50]  Thomas A Trikalinos,et al.  Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. , 2006, American journal of epidemiology.

[51]  J. J. Wang,et al.  The prevalence of age-related maculopathy: the visual impairment project. , 2000, Ophthalmology.

[52]  A. Hofman,et al.  Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. , 2006, JAMA.

[53]  Association Between C-Reactive Protein and Age-Related Macular Degeneration , 2004 .

[54]  D. Weeks,et al.  Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. , 2005, Human molecular genetics.

[55]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[56]  B S Weir,et al.  A disequilibrium coefficient approach to Hardy-Weinberg testing. , 1989, Biometrics.

[57]  J. J. Wang,et al.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. , 1995, Ophthalmology.

[58]  Douglas G. Altman,et al.  Systematic Reviews in Health Care , 2001 .

[59]  Ammarin Thakkinstian,et al.  Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. , 2005, American journal of epidemiology.